semaglutide intestinal issues Benefits of GLP-1 Ozempic: Semaglutide is a GLP-1

Patients who push through the first four to eight weeks of treatment, with appropriate management of their symptoms, typically find that side effects improve substantially even as the dose continues to increase

Even if both are the same concentration, combining them introduces unnecessary contamination risk and makes tracking the 28-day expiration window impossible

Candidates for GLP1 weight loss medications typically have a body mass index (BMI) in the overweight or obese range and may have weightrelated health concerns such as prediabetes, type 2 diabetes, high blood pressure, or elevated cholesterol

it requires ongoing injections, and discontinuation can lead to rapid weight regain, undermining long-term weight management efforts